Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 1
Submit an article Journal homepage
548
Views
24
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors

H. Jean KhouryEmory University School of Medicine, Atlanta, GA, USACorrespondence[email protected]
,
Jorge CortesUniversity of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Michele BaccaraniInstitute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
,
Meir WetzlerRoswell Park Cancer Institute, Buffalo, NY, USA
,
Tamas MassziSt. István and St. László Hospital, Budapest, Hungary
,
Raghunadharao DigumartiNizam's Institute of Medical Sciences, Hyderabad, India
,
Adam CraigChemGenex Pharmaceuticals, a wholly owned subsidiary of Teva Branded Pharmaceutical Products R&D, Inc., Frazer, PA, USA
,
Annie-Claude BenichouChemGenex Pharmaceuticals, a wholly owned subsidiary of Teva Branded Pharmaceutical Products R&D, Inc., Frazer, PA, USA
&
Luke AkardIndiana Blood and Marrow Transplantation Franciscan Alliance, Indianapolis, IN, USA
 show all
Pages 120-127 | Received 14 Oct 2013, Accepted 28 Jan 2014, Published online: 28 Apr 2014

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Sylwia Flis & Tomasz Chojnacki. (2019) Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities. Drug Design, Development and Therapy 13, pages 825-843.
Read now
Andrés Gomez-de-León, David Gómez-Almaguer, Guillermo J. Ruiz-Delgado & Guillermo J. Ruiz-Arguelles. (2017) Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective. Expert Review of Hematology 10:9, pages 809-819.
Read now
Salvatore Perrone, Fulvio Massaro, Giuliana Alimena & Massimo Breccia. (2016) How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety. Expert Opinion on Pharmacotherapy 17:11, pages 1517-1526.
Read now
Yasmin Rosshandler, Ann Q. Shen, Jorge Cortes & Hanna Jean Khoury. (2016) Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia. Expert Review of Hematology 9:5, pages 419-424.
Read now
Luke Akard, Hagop M. Kantarjian, Franck E. Nicolini, Meir Wetzler, Jeffrey H. Lipton, Michele Baccarani, H. Jean Khoury, Sandra Kurtin, Elizabeth Li, Mihaela Munteanu & Jorge Cortes. (2016) Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate. Leukemia & Lymphoma 57:3, pages 654-665.
Read now
Moussab Damlaj & Sarit Assouline. (2015) Is there a role for omacetaxine in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors?. Leukemia & Lymphoma 56:1, pages 6-7.
Read now

Articles from other publishers (18)

Joan How, Vinayak Venkataraman & Gabriela Soriano Hobbs. (2021) Blast and accelerated phase CML: room for improvement. Hematology 2021:1, pages 122-128.
Crossref
Lei Zhong, Yueshan Li, Liang Xiong, Wenjing Wang, Ming Wu, Ting Yuan, Wei Yang, Chenyu Tian, Zhuang Miao, Tianqi Wang & Shengyong Yang. (2021) Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy 6:1.
Crossref
Shi-Long Jiang, Jun-Luan Mo, Ji Peng, Lin Lei, Ji-Ye Yin, Hong-Hao Zhou, Zhao-Qian Liu & Wen-Xu Hong. (2021) Targeting translation regulators improves cancer therapy. Genomics 113:1, pages 1247-1256.
Crossref
David Snyder. 2021. Biology and Treatment of Leukemia and Bone Marrow Neoplasms. Biology and Treatment of Leukemia and Bone Marrow Neoplasms 97 114 .
Martina Bazzaro & Stig Linder. (2020) Dienone Compounds: Targets and Pharmacological Responses. Journal of Medicinal Chemistry 63:24, pages 15075-15093.
Crossref
Chung-I Wu & Haijun Wen. (2020) Heightened protein-translation activities in mammalian cells and the disease/treatment implications. National Science Review 7:12, pages 1851-1855.
Crossref
Paola Pellegrini, Karthik Selvaraju, Elena Faustini, Arjan Mofers, Xiaonan Zhang, Jens Ternerot, Alice Schubert, Stig Linder & Pádraig D′Arcy. (2020) Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570. International Journal of Molecular Sciences 21:13, pages 4757.
Crossref
Ipsita Pal, Maryam Safari, Marko Jovanovic, Susan E. Bates & Changchun Deng. (2019) Targeting Translation of mRNA as a Therapeutic Strategy in Cancer. Current Hematologic Malignancy Reports 14:4, pages 219-227.
Crossref
Matteo Molica, Emilia Scalzulli, Gioia Colafigli, Robin Foà & Massimo Breccia. (2019) Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia. Therapeutic Advances in Hematology 10, pages 204062071982644.
Crossref
Fu-Shuang Li & Jing-Ke Weng. (2017) Demystifying traditional herbal medicine with modern approach. Nature Plants 3:8.
Crossref
Xia Li, Xiufeng Yin, Huafeng Wang, Jiansong Huang, Mengxia Yu, Zhixin Ma, Chenying Li, Yile Zhou, Xiao Yan, ShuJuan Huang & Jie Jin. (2017) The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia. Oncotarget 8:8, pages 12764-12774.
Crossref
Joëlle Pérard-Viret, Laith Quteishat, Rana Alsalim, Jacques Royer & Françoise Dumas. 2017. 205 352 .
Jorge E. Cortes, H. Jean Khoury, Hagop Kantarjian, Tim H. Brümmendorf, Michael J. Mauro, Ewa Matczak, Dmitri Pavlov, Jean M. Aguiar, Kolette D. Fly, Svetoslav Dimitrov, Eric Leip, Mark Shapiro, Jeff H. Lipton, Jean-Bernard Durand & Carlo Gambacorti-Passerini. (2016) Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib. American Journal of Hematology 91:6, pages 606-616.
Crossref
Uday Deotare, Dennis Dong Hwan Kim & Jeffrey H. Lipton. (2016) Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase. Drugs & Aging 33:5, pages 335-345.
Crossref
Sudipto Mukherjee & Matt Kalaycio. (2016) Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase. Current Hematologic Malignancy Reports 11:2, pages 86-93.
Crossref
Franck E. Nicolini, Marie Balsat, Hélène Labussière-Wallet, Mohamad Sobh, Arthur Bert & Maël Heiblig. 2016. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia 147 159 .
Zachariah DeFilipp & Hanna Jean Khoury. (2015) Management of Advanced-Phase Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports 10:2, pages 173-181.
Crossref
Geoffroy Venton, Julien Colle, Cedric Mercier, Raphaelle Fanciullino, Joseph Ciccolini, Vadim Ivanov, Pierre Suchon, Gerard Sebahoun, Nathalie Beaufils, Jean Gabert, Djamal Hadjaj & Regis Costello. (2015) Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case report. Pharmacogenomics 16:7, pages 677-679.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.